» Articles » PMID: 7652768

HLA -A, -B, -DR Haplotype Frequencies in France--implications for Recruitment of Potential Bone Marrow Donors

Overview
Journal Transplantation
Specialty General Surgery
Date 1995 Aug 27
PMID 7652768
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

We have undertaken a study of the haplotypes among French potential bone marrow donors in order to define the geographical regions of France with the maximum of polymorphism and also to develop a strategy for optimal donor recruitment. A maximum likelihood estimator was used to calculate haplotype frequencies and their support limits for each region and for the whole of France. The observed differences between the regions were statistically significant. For each region, the minimum number of haplotypes necessary to explain 50% of the total frequency was calculated and compared with the equivalent values, and confidence intervals, obtained by repeated random samplings from the overall file. This approach shows that some regions (e.g., Provence) appear to be richer in terms of the numbers of haplotypes observed, and others (e.g., Bretagne) poorer. In the latter case, however, the frequencies of the most common haplotypes are greater. The haplotype frequencies of the whole sample were used to calculate the probability of finding a match for the next potential recipient for given sizes of the donor file, assuming random selection of donors. They were also used to calculate expected numbers of the major phenotypes, assuming Hardy-Weinberg equilibrium, and these were compared with those observed in the real data file. In this way, a large number of under-represented and nonrepresented phenotypes were identified. For each of these phenotypes, the most probable haplotypes and the regions in which these have the greatest frequencies have been identified. A search for donors with such particular phenotypes would be much more fruitful if directed towards these regions.

Citing Articles

HLA Linked Regional Differences in Donor Selection: A 9-Year Study of the Swiss Registry.

Kursteiner O, Nicoloso G, Demont T, Buchler M, Tiercy J Transfus Med Hemother. 2023; 50(6):539-546.

PMID: 38089494 PMC: 10712986. DOI: 10.1159/000530580.


Immunogenetics in stem cell donor registry work: The DKMS example (Part 1).

Schmidt A, Sauter J, Baier D, Daiss J, Keller A, Klussmeier A Int J Immunogenet. 2020; 47(1):13-23.

PMID: 31903698 PMC: 7003907. DOI: 10.1111/iji.12471.


Toward an optimal global stem cell donor recruitment strategy.

Schmidt A, Sauter J, Pingel J, Ehninger G PLoS One. 2014; 9(1):e86605.

PMID: 24497958 PMC: 3907384. DOI: 10.1371/journal.pone.0086605.


The heterogeneous HLA genetic makeup of the Swiss population.

Buhler S, Nunes J, Nicoloso G, Tiercy J, Sanchez-Mazas A PLoS One. 2012; 7(7):e41400.

PMID: 22848484 PMC: 3405111. DOI: 10.1371/journal.pone.0041400.


Risk assessment in haematopoietic stem cell transplantation: histocompatibility.

Petersdorf E Best Pract Res Clin Haematol. 2007; 20(2):155-70.

PMID: 17448954 PMC: 3680359. DOI: 10.1016/j.beha.2006.09.001.